Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.34 |
| ▸ | RXRA | P19793 | 2/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13845113 | 0.88 | NR1I2 (0.35) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL13090405 | 0.86 | GRIK1 (0.32) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL3068622 | 0.86 | ALDH1A1 (0.41) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL3068618 | 0.86 | ALDH1A1 (0.41) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL3208533 | 0.85 | ADORA3 (0.40) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL442023 | 0.82 | ADORA3 (0.47) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL3205323 | 0.82 | ADORA3 (0.47) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL444331 | 0.82 | ADORA3 (0.47) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL3696782 | 0.82 | ADORA3 (0.47) | GRIK1GRIK2ADORA3NR1I2PTGS2 | |
| SCHEMBL3205311 | 0.82 | ADORA3 (0.47) | GRIK1GRIK2ADORA3NR1I2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034842-B2 | Compounds | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-10-11 | — | — | US | disclosed |
| US-20080300306-A1 | Novel Compounds | BRYHN MORTEN | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300306-A1 | Novel Compounds | GPR119, FFAR2, ALOX12 | GRIK1 2174/4885GRIK2 1389/4885ADORA3 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.